Panlong Pharmaceutical: In the first half of 2025, the net profit was 60.1352 million yuan, a year-on-year increase of 0.81%

Panlong Pharmaceutical announced that in the first half of 2025, operating revenue reached 574 million yuan, a year-on-year increase of 26.06%. Net profit was 60.1352 million yuan, a year-on-year increase of 0.81%. The company plans to distribute a cash dividend of 1 yuan for every 10 shares based on a total of 106 million shares to all shareholders